Cover Image

Author Correction: FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression

Saved in:

Bibliographic Details
Main Authors:	Zhonglong Liu (Author), Xiaoyan Meng (Author), Yuxin Zhang (Author), Jingjing Sun (Author), Xiao Tang (Author), Zhiyuan Zhang (Author), Liu Liu (Author), Yue He (Author)
Format:	Book
Published:	Nature Publishing Group, 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression
by: Zhonglong Liu, et al.
Published: (2024)

Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma
by: Shengming Xu, et al.
Published: (2024)

Aberrant glycosylation in schizophrenia: insights into pathophysiological mechanisms and therapeutic potentials
by: Yanchen Feng, et al.
Published: (2024)

Aberrant Expressions and Variant Screening of SEMA3D in Indonesian Hirschsprung Patients
by: Gunadi, et al.
Published: (2020)

FUT8: AN EMERGING DRIVER OF METASTASIS
by: Zil-, et al.
Published: (2024)

The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma
by: Li K, et al.
Published: (2023)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021)

ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma
by: Jianmin Liu, et al.
Published: (2024)

Bibliometric analysis of immunotherapy for head and neck squamous cell carcinoma
by: Xin-Jia Cai, et al.
Published: (2023)

Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer's disease
by: Yue Wang, et al.
Published: (2024)

p16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma
by: Yue Wang, et al.
Published: (2024)

Docetaxel in the treatment of squamous cell carcinoma of the head and neck
by: Alexander Rapidis, et al.
Published: (2008)

MAPKs activation in head and neck squamous cell carcinomas
by: Daniele Maggioni, et al.
Published: (2011)

CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma
by: Zhichao Zhang, et al.
Published: (2024)

Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
by: Yuhong Huang, et al.
Published: (2024)

YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma
by: Junquan Weng, et al.
Published: (2022)

Oral metronomic therapy in head and neck cancer - Authors' reply
by: Vijay Patil, et al.
Published: (2021)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
by: Muzaffar Shah-Khan, et al.
Published: (2013)

Cancer stem cells in head and neck squamous cell carcinoma
by: Harish A Kumar, et al.
Published: (2023)

Study of EGFR mutations in head and neck squamous cell carcinomas
by: Gurpreet Kaur, et al.
Published: (2021)

Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy
by: Xinhai Zhang, et al.
Published: (2020)

FUT7 Promotes the Epithelial–Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma
by: Liu M, et al.
Published: (2021)

Variables alélicas del gen FUT2
by: Liliana Racca, et al.
Published: (2007)

Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma
by: Shaokun Liu, et al.
Published: (2023)

A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma
by: Zeng-Hong Wu, et al.
Published: (2020)

Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment
by: Qiu-Chi Ran, et al.
Published: (2021)

The expression of immune co-stimulators as a prognostic predictor of head and neck squamous cell carcinomas and oral squamous cell carcinomas
by: Shi-Rou Chang, et al.
Published: (2024)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
by: Xing-xing Huo, et al.
Published: (2021)

Reliability and validity of the Chinese version of the Head and Neck Information Needs Questionnaire for patients with head and neck cancer and their caregivers
by: Yu Li, et al.
Published: (2021)

Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts
by: Li-Jie Li, et al.
Published: (2021)

Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients
by: Petr Kosztyu, et al.
Published: (2018)

DISEASE RECURRENCE PREDICTORS FOR PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA
by: Yuniardini S. Wimardhani, et al.
Published: (2015)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
by: Areeg Elmusrati, et al.
Published: (2021)

Molecular genetics of head and neck squamous cell carcinoma: A review
by: B. Kolude, et al.
Published: (2015)

Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
by: Jing Yang, et al.
Published: (2024)

Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
by: Aidan G. Major, et al.
Published: (2013)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
by: Eiichi Sasaki, et al.
Published: (2020)

Reduced Expression of Galectin-8 May Contribute in Carcinogenic Pathway of Head and Neck Squamous Cell Carcinoma
by: Maryam Ghasemi, et al.
Published: (2021)

Historical Portrait of Prof. Dr. Sema Kut
by: Sema Kut
Published: (2013)

Pharmacy education in Saudi Arabia: A vision of the fut
by: Hisham Aljadhey, et al.
Published: (2017)